Well Lead Medical Co., Ltd. (SHA:603309)
China
· Delayed Price · Currency is CNY 13.72
+0.16 (1.18%)
Apr 29, 2026, 3:00 PM CST
Well Lead Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 88.15 | 87.13 | 219.39 | 192.49 | 166.57 | 106.09 | Upgrade
|
| Depreciation & Amortization | 90.72 | 90.72 | 70.03 | 72.62 | 65.52 | 57.74 | Upgrade
|
| Other Amortization | 4.57 | 4.57 | 8.47 | 4.32 | 2.61 | 1.62 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.04 | -0.04 | -0.43 | -0.09 | -0.04 | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 155.38 | 155.38 | 1.34 | 0.46 | 7.57 | 0.56 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.68 | -1.68 | -7.25 | -8.61 | -5.99 | 4.84 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 0.21 | 0.79 | -1.4 | 0.83 | Upgrade
|
| Other Operating Activities | 75.33 | 23.07 | 27.59 | 30.5 | 27.78 | 21.9 | Upgrade
|
| Change in Accounts Receivable | -10.11 | -10.11 | 14.46 | -74.04 | 59.98 | -20.32 | Upgrade
|
| Change in Inventory | -30.03 | -30.03 | -34.84 | 8.28 | -5.21 | -36.94 | Upgrade
|
| Change in Accounts Payable | 10.44 | 10.44 | 5.74 | -6.75 | 52.7 | 50.48 | Upgrade
|
| Change in Other Net Operating Assets | - | - | -4.23 | 2.59 | 21 | 3.22 | Upgrade
|
| Operating Cash Flow | 383.53 | 330.26 | 306.26 | 222.51 | 391.13 | 187.28 | Upgrade
|
| Operating Cash Flow Growth | 35.60% | 7.83% | 37.64% | -43.11% | 108.84% | -18.02% | Upgrade
|
| Capital Expenditures | -224.09 | -206.15 | -315.73 | -357.89 | -181.38 | -109.28 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.24 | 0.32 | 1.93 | 0.34 | 0.08 | 2.94 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -33.44 | Upgrade
|
| Investment in Securities | -35.24 | -46.53 | 50.89 | 15.19 | -388.31 | -17.16 | Upgrade
|
| Other Investing Activities | 2.83 | 2.79 | 7.26 | 17.91 | 9.67 | 0.6 | Upgrade
|
| Investing Cash Flow | -256.26 | -249.57 | -255.65 | -324.45 | -559.93 | -156.34 | Upgrade
|
| Long-Term Debt Issued | - | 208.88 | 403.14 | 338.44 | 177.1 | 134.9 | Upgrade
|
| Long-Term Debt Repaid | - | -124.74 | -325.3 | -215.93 | -169.55 | -75.27 | Upgrade
|
| Total Debt Repaid | -111.93 | -124.74 | -325.3 | -215.93 | -169.55 | -75.27 | Upgrade
|
| Net Debt Issued (Repaid) | 75.07 | 84.15 | 77.85 | 122.51 | 7.56 | 59.63 | Upgrade
|
| Issuance of Common Stock | 0.26 | - | - | - | 0.69 | 417.66 | Upgrade
|
| Repurchase of Common Stock | - | - | -1.97 | -1.06 | -1.36 | - | Upgrade
|
| Common Dividends Paid | -217.19 | -159.2 | -155.6 | -106.84 | -45.49 | -58.56 | Upgrade
|
| Other Financing Activities | -54.9 | -51.3 | 12.02 | -2.95 | -8.3 | -4.86 | Upgrade
|
| Financing Cash Flow | -196.76 | -126.35 | -67.71 | 11.66 | -46.91 | 413.88 | Upgrade
|
| Foreign Exchange Rate Adjustments | -4.45 | -2.81 | 1.87 | 1.71 | 2.58 | -2.1 | Upgrade
|
| Net Cash Flow | -73.94 | -48.48 | -15.23 | -88.57 | -213.14 | 442.72 | Upgrade
|
| Free Cash Flow | 159.44 | 124.11 | -9.47 | -135.38 | 209.75 | 78 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 168.90% | -42.63% | Upgrade
|
| Free Cash Flow Margin | 9.72% | 7.61% | -0.63% | -9.75% | 15.38% | 6.97% | Upgrade
|
| Free Cash Flow Per Share | 0.55 | 0.42 | -0.03 | -0.46 | 0.72 | 0.30 | Upgrade
|
| Cash Income Tax Paid | 46.82 | 46.82 | 19.13 | 43.92 | 51.41 | 45.9 | Upgrade
|
| Levered Free Cash Flow | 72.11 | 69.08 | -64.12 | -230.71 | 151.53 | 58.19 | Upgrade
|
| Unlevered Free Cash Flow | 72.81 | 69.08 | -56.42 | -225.01 | 156.45 | 63.5 | Upgrade
|
| Change in Working Capital | -28.9 | -28.9 | -13.1 | -69.95 | 128.49 | -6.31 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.